← All organizations

Taiyo

For profit

Also known as: TAIYO EUROPE

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 1, 2009

Acquired by Teva on Jul 25, 2011

Timeline

1930s

Jan 1, 1930
Taiyo— Founded

2010s

Jul 25, 2011
Teva— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

l-epigallocatechin

Indications

Studied for

Recent trials (1)

NCT00799890CollaboratorPhase 2/Phase 3May 1, 2009

Details

Founded: Takayama, JP Jan 1, 1930
Last known activity: May 1, 2009